atenolol has been researched along with Hyperlipemia in 19 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adverse alterations in lipid profile suggesting higher atherogenicity were observed following 12 weeks treatment with atenolol in patients of hypertension." | 5.07 | Effect of atenolol and labetalol on serum lipids. ( Dahiya, SS; Seth, RK; Seth, S; Sharma, D; Siwach, SB, 1993) |
| "The lipophilic beta-adrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients." | 2.71 | Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. ( Droździk, M; Gawrońska-Szklarz, B; Jaroszynska, M; Pawlik, A; Sterna, R; Wójcicki, J, 2003) |
| " In the light of the results obtained, the following conclusions were drawn: 1) hyperlipidemia affects pharmacodynamic properties of lipophilic propranolol and hydrophilic atenolol, 2) a modification of the drug dosage in hyperlipidemia is warranted." | 2.71 | [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol]. ( Droździk, M; Gawrońska-Szklarz, B; Sterna, R; Sulzyc-Bielicka, V; Telatyńska-Smieszek, B; Wójcicki, J, 2004) |
| " Pharmacokinetic parameters were calculated according to the noncompartmental open model." | 2.70 | [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension]. ( Telatyńska-Smieszek, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Patel, A | 1 |
| Cass, A | 1 |
| Peiris, D | 1 |
| Usherwood, T | 1 |
| Brown, A | 1 |
| Jan, S | 1 |
| Neal, B | 1 |
| Hillis, GS | 1 |
| Rafter, N | 1 |
| Tonkin, A | 1 |
| Webster, R | 1 |
| Billot, L | 1 |
| Bompoint, S | 1 |
| Burch, C | 1 |
| Burke, H | 1 |
| Hayman, N | 1 |
| Molanus, B | 1 |
| Reid, CM | 1 |
| Shiel, L | 1 |
| Togni, S | 1 |
| Rodgers, A | 1 |
| Veeraputhiran, M | 1 |
| Sundermeyer, M | 1 |
| Ara, N | 1 |
| Rashid, M | 1 |
| Amran, MS | 1 |
| Wójcicki, J | 2 |
| Jaroszynska, M | 1 |
| Droździk, M | 2 |
| Pawlik, A | 1 |
| Gawrońska-Szklarz, B | 2 |
| Sterna, R | 2 |
| Rizos, E | 1 |
| Bairaktari, E | 1 |
| Kostoula, A | 1 |
| Hasiotis, G | 1 |
| Achimastos, A | 1 |
| Ganotakis, E | 1 |
| Elisaf, M | 1 |
| Mikhailidis, DP | 1 |
| Talbert, RL | 1 |
| Pieper, JA | 1 |
| Ito, MK | 1 |
| Oganov, RG | 1 |
| Lepakhin, VK | 1 |
| Fitilev, SB | 1 |
| Levin, AM | 1 |
| Titarova, YY | 1 |
| Sytchev, EN | 1 |
| Diener, HC | 1 |
| Telatyńska-Smieszek, B | 2 |
| Sulzyc-Bielicka, V | 1 |
| Iaccarino, G | 1 |
| Trimarco, V | 1 |
| Lanni, F | 1 |
| Cipolletta, E | 1 |
| Izzo, R | 1 |
| Arcucci, O | 1 |
| De Luca, N | 1 |
| Di Renzo, G | 1 |
| Morel, Y | 1 |
| Gadient, A | 1 |
| Keller, U | 1 |
| Vadas, L | 1 |
| Golay, A | 1 |
| Siwach, SB | 1 |
| Dahiya, SS | 1 |
| Seth, S | 1 |
| Seth, RK | 1 |
| Sharma, D | 1 |
| Andersen, P | 1 |
| Seljeflot, I | 1 |
| Herzog, A | 1 |
| Arnesen, H | 1 |
| Hjermann, I | 1 |
| Holme, I | 1 |
| Bory, M | 1 |
| Boccalandro, F | 1 |
| Farias, J | 1 |
| Boccalandro, C | 1 |
| Vaisman, D | 1 |
| Nafstad, I | 1 |
| Tollersrud, S | 1 |
| Eriksen, K | 1 |
| Helgeland, A | 1 |
| Solberg, LA | 1 |
| Bredesen, J | 1 |
| Dale, O | 1 |
| Brook, JG | 1 |
| Marmur, A | 1 |
| Berkovitch, Y | 1 |
| Aviram, M | 1 |
1 review available for atenolol and Hyperlipemia
| Article | Year |
|---|---|
[Does diabetes change the anti-ischemic therapeutic options in the symptomatic coronary patient?].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Atenolol; Como | 2000 |
9 trials available for atenolol and Hyperlipemia
| Article | Year |
|---|---|
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme In | 2015 |
Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Area Under Curve; Atenolol; Blood Pressure | 2003 |
The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
Topics: Adrenergic beta-Antagonists; Anticholesteremic Agents; Atenolol; Benzopyrans; Drug Therapy, Combinat | 2003 |
[Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cross-Over Studies; Female; Humans; Hyperlipidemias; M | 2002 |
[Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Area Under Curve; Atenolol; Blood Pressure; Chrom | 2004 |
Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aten | 1995 |
Effect of atenolol and labetalol on serum lipids.
Topics: Atenolol; Female; Humans; Hyperlipidemias; Hypertension; Labetalol; Lipids; Male | 1993 |
Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men.
Topics: Adult; Antihypertensive Agents; Atenolol; Cholesterol, HDL; Doxazosin; Female; Fibrinolysis; Gonadal | 1998 |
Frequency of postprandial lipemia after a first acute coronary event (unstable angina pectoris or non-ST-segment elevation acute myocardial infarction) and the effects of atenolol on the lipemia.
Topics: Angina, Unstable; Area Under Curve; Atenolol; Cholesterol; Fasting; Female; Humans; Hyperlipidemias; | 2002 |
9 other studies available for atenolol and Hyperlipemia
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensiv | 2008 |
Comparison of hypotensive and hypolipidemic effects of Catharanthus roseus leaves extract with atenolol on adrenaline induced hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Body Weight; Catharanthus | 2009 |
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studies.
Topics: Aspirin; Atenolol; Blood Chemical Analysis; Coronary Disease; Female; Humans; Hyperlipidemias; Hyper | 2003 |
[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Angiotens | 2003 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic | 2003 |
beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Anta | 2005 |
The influence of atenolol and prazosin on serum lipids and atherosclerosis in minipigs fed a hyperlipidemic diet.
Topics: Animals; Arteriosclerosis; Atenolol; Body Weight; Cholesterol, Dietary; Diet; Female; gamma-Glutamyl | 1988 |
Platelet adhesion in hyperlipidemic and hypertensive patients.
Topics: Adult; Arteriosclerosis; Atenolol; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinem | 1985 |